查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599726

血糖值测量市场：按产品、年龄层、应用、最终用户、分销管道 - 全球预测 2025-2030

Blood Glucose Testing Market by Product (Glucose Meter, Insulin Pens, Insulin Pumps & Reservoirs), Age Group (Adults, Geriatrics, Pediatrics), Application, End-User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血糖值测量市场规模为193.7亿美元，预计2024年将达212.1亿美元，复合年增长率为9.76%，预计2030年将达372亿美元。

血糖值测量市场范围包括测量血糖水平的设备和技术，这对于糖尿病管理至关重要。监测血糖值对于有效管理糖尿病是必要的，因为维持适当的血糖值可以预防併发症。该应用扩展到慢性病管理、家庭保健和医院。最终用途范围包括诊断中心、医疗机构和在家自我测量的个别患者等多种领域。主要影响成长要素是糖尿病盛行率增加、健康意识提高、技术进步以及向微创或非侵入性产品的转变。与连续血糖监测仪 (CGM) 和云端基础的平台整合的智慧医疗设备的激增正在创造新的商机。这些可以实现即时资料分析，改善患者治疗结果，并提供远端医疗解决方案等新颖的业务提案。电子医疗的扩展和量身定制的患者照护策略为寻求竞争优势的市场领导带来了希望。然而，市场面临限制和挑战，例如先进设备的高成本、严格的监管环境以及与资料监控相关的隐私问题。此外，技术依赖性可能会导致采用方面的差异，特别是在资源匮乏的环境中。创新和研究的机会包括开发具有成本效益的模型，提高准确性和易用性，特别是针对微创解决方案。将血糖监测与其他健康指标结合的综合健康平台的进一步研究是一个富有成效的创新领域。全球研究合作可以产生研究工作的协同效应，增强产品功能并扩大市场范围。市场动态是充满活力和竞争的，其特点是快速的技术创新和高消费者期望。企业应专注于加强资料安全和监管合规性，同时投资消费者教育和可负担性策略，以加强其市场占有率和成长。

主要市场统计
基准年[2023] 193.7亿美元
预测年份 [2024] 212.1亿美元
预测年份 [2030] 372亿美元
复合年增长率（%） 9.76%

市场动态：快速发展的血糖值测量市场的关键市场洞察

供需的动态交互作用正在改变血糖值测量市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球糖尿病发生率上升以及对有效血糖监测解决方案的需求
    • 在家庭医疗保健中越来越多地采用非侵入性血糖值测量设备
  • 市场限制因素
    • 血糖值测量设备高成本且精度有限
  • 市场机会
    • 政府对血糖值监测的优惠措施与报销政策
    • 血糖监测设备的不断进步与改进
  • 市场挑战
    • 严格的监管要求和产品召回案例

波特五力：驾驭血糖值测量市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对血糖值测量市场的影响

外部宏观环境因素在塑造血糖值测量市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血糖值测量市场的竞争状况

对血糖值监测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵血糖值测量市场厂商绩效评估

FPNV定位矩阵是评估血糖值测量市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划血糖值测试市场的成功之路

血糖值测量市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球糖尿病发生率上升，需要有效的血糖监测解决方案
      • 在家庭医疗保健环境中越来越多地采用非侵入性血糖值测量设备
    • 抑制因素
      • 血糖值测量设备高成本且精度有限
    • 机会
      • 政府对血糖值测量的有利措施和报销政策
      • 血糖值监测设备的不断进步与改进
    • 任务
      • 严格的监管要求和产品召回案例
  • 市场区隔分析
    • 产品：采用CGM系统进行血糖值测量，避免严重的短期及长期糖尿病併发症
    • 应用：增加妊娠糖尿病中血糖值监测的使用，降低与多种慢性疾病相关的风险
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血糖值测量市场：副产品

  • 血糖仪
    • 连续血糖监测
    • 快速血糖监测
  • 胰岛素笔
  • 胰岛素帮浦和储液器
  • 采血针
  • 试纸条

第七章血糖值测量市场：依年龄组

  • 成人
  • 老年医学
  • 小儿科

第八章血糖值测量市场：依应用分类

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第九章血糖值测量市场：依最终用户分类

  • 居家护理
  • 医院/诊所

第10章血糖值测量市场：按分销管道

  • 离线
  • 在线的

第十一章北美和南美血糖值测量市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太血糖值测量市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的血糖值测量市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Focus与GlucoTrack合作开发植入式连续血糖监测仪
    • Beurer India 在印度市场推出血糖值监测设备
    • MTD 收购 Ipsomed 的笔针和背景音乐业务，巩固在糖尿病护理领域的地位
  • 战略分析和建议

公司名单

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • ForaCare Suisse AG
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medisana AG
  • Medtronic PLC
  • Merck KGaA
  • Microlife AG
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Omron Healthcare, Inc.
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi SA
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.
Product Code: MRR-030666397D38

The Blood Glucose Testing Market was valued at USD 19.37 billion in 2023, expected to reach USD 21.21 billion in 2024, and is projected to grow at a CAGR of 9.76%, to USD 37.20 billion by 2030.

The scope of the blood glucose testing market involves devices and technologies that measure glucose levels in the blood, crucial for diabetes management. Blood glucose monitoring is necessary to manage diabetes effectively, as maintaining the appropriate blood glucose levels prevents complications. This application extends to chronic disease management, home healthcare, and hospitals. The end-use scope includes diverse sectors such as diagnostic centers, healthcare institutions, and individual patients self-monitoring at home. Key influencing growth factors are the increasing prevalence of diabetes, rising health awareness, advancements in technology, and the shift towards minimally invasive or non-invasive products. The widespread adoption of continuous glucose monitors (CGMs) and smart medical devices integrated with cloud-based platforms offers fresh opportunities. These allow real-time data analytics, improving patient outcomes and offering novel business proposals, such as telehealth solutions. The expansion of e-health and tailored patient-care strategies is promising for market leaders aiming to gain a competitive edge. However, the market faces limitations and challenges, such as the high costs of advanced devices, stringent regulatory landscapes, and privacy concerns associated with data monitoring. Moreover, technological dependency may result in disparities in adoption, particularly in low-resource settings. Opportunities for innovation and research include developing cost-effective models with enhanced accuracy and ease of use, especially targeting minimally invasive solutions. Further research into integrated wellness platforms that combine glucose monitoring with other health metrics is a lucrative innovation area. Global collaborations can lead to synergized research efforts, enriching product features and expanding market reach. The nature of the blood glucose testing market is dynamic and competitive, characterized by rapid technological changes and high consumer expectations. Firms should focus on enhancing data security and regulatory compliance, alongside investing in consumer education and affordable pricing strategies, to bolster market presence and growth.

KEY MARKET STATISTICS
Base Year [2023] USD 19.37 billion
Estimated Year [2024] USD 21.21 billion
Forecast Year [2030] USD 37.20 billion
CAGR (%) 9.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Testing Market

The Blood Glucose Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Global rise in diabetes incidence and the need for effective glucose monitoring solutions
    • Rising adoption of non-invasive blood glucose testing devices in home healthcare settings
  • Market Restraints
    • High costs and limited accuracy of blood glucose testing devices
  • Market Opportunities
    • Favorable government initiatives and reimbursement policies for blood glucose testing
    • Ongoing advancements and improvements in blood glucose monitoring devices
  • Market Challenges
    • Strict regulatory requirements and cases of product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Testing Market

A detailed market share analysis in the Blood Glucose Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Testing Market

A strategic analysis of the Blood Glucose Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc, AgaMatrix, Inc., ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Medical Ltd., Becton Dickinson and Company, Beurer Belgium, Dexcom, Inc., ForaCare Suisse AG, i-SENS, Inc., Johnson & Johnson, LifeScan IP Holdings, LLC, Medisana AG, Medtronic PLC, Merck KGaA, Microlife AG, Neogen Corporation, Nipro Corporation, Nova Biomedical, Omron Healthcare, Inc., Roche Diagnostics Nederland BV, Rossmax International Ltd., Sanofi S.A., Sinocare Inc., Terumo Corporation, Trividia Health, Inc., and VivaChek Laboratories Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Glucose Meter, Insulin Pens, Insulin Pumps & Reservoirs, Lancets, and Test Strips. The Glucose Meter is further studied across Continuous Glucose Monitoring and Flash Glucose Monitoring.
  • Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
  • Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on End-User, market is studied across Home Care and Hospital & Clinics.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Global rise in diabetes incidence and the need for effective glucose monitoring solutions
      • 5.1.1.2. Rising adoption of non-invasive blood glucose testing devices in home healthcare settings
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and limited accuracy of blood glucose testing devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives and reimbursement policies for blood glucose testing
      • 5.1.3.2. Ongoing advancements and improvements in blood glucose monitoring devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory requirements and cases of product recalls
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Adoption of CGM systems in blood glucose to avoid serious, short- and long-term diabetes complications
    • 5.2.2. Application: Increasing uses of blood glucose testing in gestational diabetes to mitigate risks associated with several chronic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Glucose Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Glucose Meter
    • 6.2.1. Continuous Glucose Monitoring
    • 6.2.2. Flash Glucose Monitoring
  • 6.3. Insulin Pens
  • 6.4. Insulin Pumps & Reservoirs
  • 6.5. Lancets
  • 6.6. Test Strips

7. Blood Glucose Testing Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Geriatrics
  • 7.4. Pediatrics

8. Blood Glucose Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Care
  • 9.3. Hospital & Clinics

10. Blood Glucose Testing Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Blood Glucose Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Focus collaborates with GlucoTrack on implantable continuous blood glucose monitor
    • 14.3.2. Beurer India launches blood glucose monitor device in the Indian market
    • 14.3.3. MTD acquires Ypsomed's Pen Needle and BGM Businesses, strengthening Its position in diabetes care
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 77 Elektronika Kft.
  • 2. Abbott Laboratories
  • 3. ACON Laboratories, Inc
  • 4. AgaMatrix, Inc.
  • 5. ARKRAY, Inc.
  • 6. Ascensia Diabetes Care Holdings AG
  • 7. B. Braun Medical Ltd.
  • 8. Becton Dickinson and Company
  • 9. Beurer Belgium
  • 10. Dexcom, Inc.
  • 11. ForaCare Suisse AG
  • 12. i-SENS, Inc.
  • 13. Johnson & Johnson
  • 14. LifeScan IP Holdings, LLC
  • 15. Medisana AG
  • 16. Medtronic PLC
  • 17. Merck KGaA
  • 18. Microlife AG
  • 19. Neogen Corporation
  • 20. Nipro Corporation
  • 21. Nova Biomedical
  • 22. Omron Healthcare, Inc.
  • 23. Roche Diagnostics Nederland BV
  • 24. Rossmax International Ltd.
  • 25. Sanofi S.A.
  • 26. Sinocare Inc.
  • 27. Terumo Corporation
  • 28. Trividia Health, Inc.
  • 29. VivaChek Laboratories Inc.

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GLUCOSE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY INSULIN PUMPS & RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY GLUCOSE METER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023